Clinical isolates of Enterococcus faecalis aggregate human platelets

Microbes and Infection

Volumn 12, Issue 4, 2010, Pages 295-301

  Rasmussen, Magnus ^a   Johansson, Daniel ^a   Söbirk, Sara K ^a,b   Mörgelin, Matthias ^a   Shannon, Oonagh ^a  

^a LUND UNIVERSITY   (Sweden)

^b University and Regional Laboratories ^*  (Sweden)

Author keywords

Enterococcus faecalis; Infective endocarditis; Platelet activation

Indexed keywords

ANTIBODY; FC RECEPTOR IIA; FIBRINOGEN; IMMUNOGLOBULIN G; PROTEINASE;

ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOOD; BLOOD DONOR; ENTEROCOCCUS FAECALIS; HOST; HUMAN; NONHUMAN; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; URINE;

BLOOD; BLOOD PLATELETS; ENTEROCOCCUS FAECALIS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOGLOBULIN G; PLATELET ACTIVATION; PLATELET AGGREGATION; TIME FACTORS; URINE;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS;

EID: 77649275866     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.01.005     Document Type: Article

References (30)

1. McDonald J.R., Olaison L., Anderson D.J., Hoen B., Miro J.M., Eykyn S., Abrutyn E., Fowler Jr. V.G., Habib G., Selton-Suty C., Pappas P.A., Cabell C.H., Corey G.R., Marco F., and Sexton D.J. Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database. Am. J. Med. 118 (2005) 759-766
2. Nallapareddy S.R., Singh K.V., Sillanpää J., Garsin D.A., Höök M., Erlandsen S.L., and Murray B.E. Endocarditis and biofilm-associated pili of Enterococcus faecalis. J. Clin. Invest. 116 (2006) 2799-2807
3. Schlievert P.M., Gahr P.J., Assimacopoulos A.P., Dinges M.M., Stoehr J.A., Harmala J.W., Hirt H., and Dunny G.M. Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. Infect. Immun. 66 (1998) 218-223
4. McCormick J.K., Tripp T.J., Dunny G.M., and Schlievert P.M. Formation of vegetations during infective endocarditis excludes binding of bacterial-specific host antibodies to Enterococcus faecalis. J. Infect. Dis. 185 (2002) 994-997
5. Fitzgerald J.R., Foster T.J., and Cox D. The interaction of bacterial pathogens with platelets. Nat. Rev. Microbiol. 4 (2006) 445-457
6. Loughman A., Fitzgerald J.R., Brennan M.P., Higgins J., Downer R., Cox D., and Foster T.J. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol. Microbiol. 57 (2005) 804-818
7. Fitzgerald J.R., Loughman A., Keane F., Brennan M., Knobel M., Higgins J., Visai L., Speziale P., Cox D., and Foster T.J. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol. Microbiol. 59 (2006) 212-230
8. Sjöbring U., Ringdahl U., and Ruggeri Z.M. Induction of platelet thrombi by bacteria and antibodies. Blood 100 (2002) 4470-4477
9. Pietrocola G., Schubert A., Visai L., Torti M., Fitzgerald J.R., Foster T.J., Reinscheid D.J., and Speziale P. FbsA, a fibrinogen-binding protein from Streptococcus agalactiae, mediates platelet aggregation. Blood 105 (2005) 1052-1059
10. Kerrigan S.W., Douglas I., Wray A., Heath J., Byrne M.F., Fitzgerald D., and Cox D. A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood 100 (2002) 509-516
11. Bensing B.A., Lopez J.A., and Sullam P.M. The Streptococcus gordonii surface proteins GspB and Hsa mediate binding to sialylated carbohydrate epitopes on the platelet membrane glycoprotein Ibalpha. Infect. Immun. 72 (2004) 6528-6537
12. Usui Y., Ichiman Y., Suganuma M., and Yoshida K. Platelet aggregation by strains of enterococci. Microbiol. Immunol. 35 (1991) 933-942
13. Ford M., Perry J.D., and Gould F.K. Use of cephalexin-aztreonam-arabinose agar for selective isolation of Enterococcus faecium. J. Clin. Microbiol. 32 (1994) 2999-3001
14. Day A.M., Sandoe J.A., Cove J.H., and Phillips-Jones M.K. Evaluation of a biochemical test scheme for identifying clinical isolates of Enterococcus faecalis and Enterococcus faecium. Lett. Appl. Microbiol. 33 (2001) 392-396
15. Rasmussen M., Müller H.P., and Björck L. Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin. J. Biol. Chem. 274 (1999) 15336-15344
16. von Pawel-Rammingen U., Johansson B.P., and Björck L. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J. 21 (2002) 1607-1615
17. Johansson B.P., Shannon O., and Björck L. IdeS: a bacterial proteolytic enzyme with therapeutic potential. PLoS One 3 (2008) e1692
18. Greenman J., Tutt A.L., George A.J., Pulford K.A., Stevenson G.T., and Glennie M.J. Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab′)2 derivative for recruitment of cytotoxic effectors. Mol. Immunol. 28 (1991) 1243-1254
19. Coller B.S. Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation 92 (1995) 2373-2380
20. Sillanpää J., Nallapareddy S.R., Houston J., Ganesh V.K., Bourgogne A., Singh K.V., Murray B.E., and Höök M. A family of fibrinogen-binding MSCRAMMs from Enterococcus faecalis. Microbiology 155 (2009) 2390-2400
21. Nallapareddy S.R., and Murray B.E. Role played by serum, a biological cue, in the adherence of Enterococcus faecalis to extracellular matrix proteins, collagen, fibrinogen, and fibronectin. J. Infect. Dis. 197 (2008) 1728-1736
22. Moreillon P., Entenza J.M., Francioli P., McDevitt D., Foster T.J., Francois P., and Vaudaux P. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Immun. 63 (1995) 4738-4743
23. Que Y.A., Haefliger J.A., Piroth L., Francois P., Widmer E., Entenza J.M., Sinha B., Herrmann M., Francioli P., Vaudaux P., and Moreillon P. Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J. Exp. Med. 201 (2005) 1627-1635
24. Sullam P.M., Bayer A.S., Foss W.M., and Cheung A.L. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect. Immun. 64 (1996) 4915-4921
25. Xiong Y.Q., Bensing B.A., Bayer A.S., Chambers H.F., and Sullam P.M. Role of the serine-rich surface glycoprotein GspB of Streptococcus gordonii in the pathogenesis of infective endocarditis. Microb. Pathog. 45 (2008) 297-301
26. Yeaman M.R. The role of platelets in antimicrobial host defense. Clin. Infect. Dis. 25 (1997) 951-968 quiz 969-970
27. Sullam P.M., Frank U., Yeaman M.R., Tauber M.G., Bayer A.S., and Chambers H.F. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J. Infect. Dis. 168 (1993) 910-914
28. Bayer A.S., Cheng D., Yeaman M.R., Corey G.R., McClelland R.S., Harrel L.J., and Fowler Jr. V.G. In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob. Agents Chemother. 42 (1998) 3169-3172
29. Kupferwasser L.I., Yeaman M.R., Shapiro S.M., Nast C.C., and Bayer A.S. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses. Circulation 105 (2002) 746-752
30. Wu T., Yeaman M.R., and Bayer A.S. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob. Agents Chemother. 38 (1994) 729-732